Your browser doesn't support javascript.
loading
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.
Yang, Hae Kyung; Min, Kyung Wan; Park, Sung Woo; Chung, Choon Hee; Park, Kyong Soo; Choi, Sung Hee; Song, Ki-Ho; Kim, Doo-Man; Lee, Moon-Kyu; Sung, Yeon-Ah; Baik, Sei Hyun; Kim, In Joo; Cha, Bong-Soo; Park, Jeong Hyun; Ahn, Yu Bae; Lee, In-Kyu; Yoo, Soon Jib; Kim, Jaetaek; Park, Ie Byung; Park, Tae Sun; Yoon, Kun-Ho.
Afiliação
  • Yang HK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 137-701, Korea.
Endocr J ; 62(5): 449-62, 2015.
Article em En | MEDLINE | ID: mdl-25819061

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article